Metronidazole

Reductive activation in anaerobic organisms generates reactive nitro radicals that damage microbial DNA and proteins.

AntimicrobialAntimicrobial action

Primary Mechanism of Action

Clinical / Scientific

In susceptible anaerobes and some protozoa, low redox potential electron-transport proteins reduce the metronidazole nitro group. The resulting radicals fragment DNA and other macromolecules. Aerobic mammalian cells activate the prodrug poorly, contributing to selective toxicity.

Pathway Targets

Anaerobic electron transport

Scientific explanation

Reductive activation of the nitroimidazole prodrug.

Microbial DNA

Scientific explanation

Radical-mediated strand damage.

Pathway Convergence

Clinical / Scientific

Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.

Redox-activated DNA injury

Target to downstream effect: Anaerobic nitroreduction → Radical formation → DNA strand breakage

Anaerobic nitroreduction
↓
Radical formation
↓
DNA strand breakage

Mechanistically Relevant Repurposed & Adjunctive Applications

Anaerobic bacterial and protozoal infections

Established

Mechanistic rationale

Established for labelled anaerobic and selected protozoal infections.

Mechanistic Application Matrix

Biological TargetMechanismPotential RelevanceEvidence Level
Microbial DNARedox-activated radicalsAnaerobe / protozoal killingEstablished mechanism

Mechanistic Interaction Considerations

Disulfiram-like alcohol reaction, warfarin potentiation, and lithium interactions are labelled considerations. Avoid fabricating additional contraindications.

In Plain Language

Inside certain low-oxygen microbes, metronidazole is switched on and becomes a reactive chemical that damages their DNA.

Compounds Sharing Pathways

Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.

Microbial DNA

Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.